Clinical Trial Update: A Phase I Study on Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics and Preliminary Efficacy of SXRN Plasmid DNA Technique in Patients With Advanced Solid Tumors [EARLY_Phase 1]

View source ↗

Summary

A Phase I study evaluating safety, tolerability, pharmacokinetics, and preliminary efficacy of SXRN plasmid DNA technique in patients with advanced solid tumors…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cachexia
• Cancer

Drugs mentioned

• SXRN Plasmid DNA Technique

Snippet

Sponsor: Jiangsu Nutai Biologics Co., Ltd | Conditions: Advanced Cancer, Cachexia | EARLY_Phase 1 | Status: COMPLETED